Nakai I, Kaufman D B, Field M J, Morel P, Sutherland D E
Department of Surgery, University of Minnesota, Minneapolis 55455.
Transplantation. 1992 Jul;54(1):17-25. doi: 10.1097/00007890-199207000-00003.
Pancreas transplant results have been better in uremic recipients of a simultaneous kidney than in nonuremic recipients of a pancreas alone. We studied the relative effect of uremia versus a double transplant on functional survival by performing bladder-drained pancreas transplants alone (PTA), kidney transplants alone (KTA), and simultaneous pancreas/kidney (SPK) transplants from Buffalo donors to diabetic Lewis rat recipients that were or were not made uremic 2-3 weeks before by 1 4/5 native nephrectomy. Pancreas graft exocrine function was monitored by urinary amylase (UA). In the PTA and SPK recipients made diabetic by streptozotocin, endocrine function was monitored by measuring nonfasting plasma glucose (PG) levels. Kidney graft function was monitored by plasma creatinine (Cr). Rejection of the endocrine pancreas was defined as an increase of PG to greater than 200 mg/dl; of the exocrine pancreas, as a decline in UA to less than 6000 U/L or to less than 100 U/24 hr; and of the kidney, as an elevation of Cr to greater than 3 mg/dl. The mean functional survival times (MST) of both the endocrine (12.0 +/- 2.1 versus 10.1 +/- 1.1 days, P = 0.036) and exocrine (8.0 +/- 2.1 versus 6.3 +/- 1.3 days, P = 0.016) components of the pancreas grafts were significantly longer in SPK than in PTA recipients. The MST of kidney allografts, however, was not significantly longer in nonuremic SPK than nonuremic KTA recipients (6.7 +/- 1.4 versus 5.7 +/- 0.7 days, P = 0.13). In parallel experiments in recipients immunosuppressed with cyclosporine, the graft survival times were longer, but the relative differences between the PTA, SPK, and KTA groups persisted. Histologically, lymphocyte infiltration began in the two organs almost simultaneously, but the severity of the rejection was more vigorous in the kidney than in the pancreas in doubly grafted rats, and destruction of pancreas grafts progressed more slowly in SPK than in PTA recipients. Preexisting uremia delayed pancreas rejection in both SPK (exocrine 10.6 +/- 2.3, P = 0.032, and endocrine 14.8 +/- 3.4 days, P = 0.065, versus nonuremics) and PTA (exocrine 8.5 +/- 1.7, P = 0.007, and endocrine 12.6 +/- 2.5, P = 0.026, versus nonuremics) nonimmunosuppressed recipients. The MST of kidney grafts was not significantly longer in uremic (8.9 +/- 2.8 days) than in nonuremic (6.7 +/- 1.4 days) SPK recipients (P = 0.081). A synchronous kidney transplant and uremia independently down-modulate the rejection response to a pancreas graft, and a simultaneous pancreas graft has no detrimental effect on the survival of a kidney graft.(ABSTRACT TRUNCATED AT 400 WORDS)
对于同时接受肾脏移植的尿毒症患者,胰腺移植的效果要优于单独接受胰腺移植的非尿毒症患者。我们通过对糖尿病Lewis大鼠受体进行单独膀胱引流胰腺移植(PTA)、单独肾脏移植(KTA)以及同时进行胰腺/肾脏移植(SPK),研究尿毒症与双重移植对功能存活的相对影响。这些受体大鼠通过切除1 4/5的自身肾脏在2 - 3周前造成或未造成尿毒症,供体均来自布法罗。通过尿淀粉酶(UA)监测胰腺移植物的外分泌功能。在通过链脲佐菌素诱导糖尿病的PTA和SPK受体中,通过测量非空腹血浆葡萄糖(PG)水平监测内分泌功能。通过血浆肌酐(Cr)监测肾脏移植物功能。内分泌胰腺的排斥反应定义为PG升高至大于200mg/dl;外分泌胰腺的排斥反应定义为UA下降至小于6000U/L或小于100U/24小时;肾脏的排斥反应定义为Cr升高至大于3mg/dl。SPK受体胰腺移植物的内分泌(12.0±2.1天对10.1±1.1天,P = 0.036)和外分泌(8.0±2.1天对6.3±1.3天,P = 0.016)成分的平均功能存活时间(MST)均显著长于PTA受体。然而,非尿毒症SPK受体的肾脏同种异体移植物的MST并不显著长于非尿毒症KTA受体(6.7±1.4天对5.7±0.7天,P = 0.13)。在使用环孢素免疫抑制的受体的平行实验中,移植物存活时间更长,但PTA、SPK和KTA组之间的相对差异仍然存在。组织学上,淋巴细胞浸润在两个器官中几乎同时开始,但在双重移植的大鼠中,肾脏的排斥反应严重程度比胰腺更剧烈,并且SPK受体中胰腺移植物的破坏进展比PTA受体更慢。预先存在的尿毒症在SPK(外分泌10.6±2.3天,P = 0.032,内分泌14.8±3.4天,P = 0.065,与非尿毒症相比)和PTA(外分泌8.5±1.7天,P = 0.007,内分泌12.6±2.5天,P = 0.026,与非尿毒症相比)未免疫抑制的受体中均延迟了胰腺排斥反应。尿毒症SPK受体的肾脏移植物的MST(8.9±2.8天)并不显著长于非尿毒症(6.7±1.4天)的SPK受体(P = 0.081)。同步肾脏移植和尿毒症独立下调对胰腺移植物的排斥反应,并且同时进行的胰腺移植对肾脏移植物的存活没有不利影响。(摘要截断于400字)